The majority of mutations are detrimental to the organisms that carry them. spread of this fatal pandemic. While the mutation that causes the Omicron variant is definitely encouraging, subsequent mutations do not assurance that the disease it causes will become less severe. As the disease continues to develop, humans must constantly adapt by increasing their immunity through vaccination. Keywords: COVID-19, SARS-CoV-2, Omicron, natural immunity, cross immunity 1. Introduction At the moment, any conversation of viruses will include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease that caused the global COVID-19 pandemic. As Peucedanol of19:50 p.m. CET on 11 March 2022, the WHO experienced confirmed 452,052,304 instances of COVID-19 worldwide, including 6,027,059 deaths. As of 5 Rabbit polyclonal to Cyclin B1.a member of the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle.Cyclins function as regulators of CDK kinases. March 2022, 10,704,043,684 doses of vaccines had been given (https://covid19.who.int/; utilized on 12 March 2022). SARS-CoV-2 was found out to be closely related to the genus Betacoronavirus [1], which is a member of the Coronaviridae family. SARS-CoV and MERS-CoV are some of the additional users of this family [2]. This disease can spread through droplets and aerosols [3] with a very high illness and transmission rate [4]. SARS-CoV-2 has a positive-sense single-strand RNA (+ssRNA) as its genetic material [5]. RNA viruses have a high mutation rate, which is definitely associated with improved virulence and adaptability, both of which are considered advantageous for viruses [6]. The mutations are primarily caused by errors in the viral RNA replication process, which results in the build up of sequences that undergo incorporation errors or go through recombination, providing rise to a variety of viral variants [7,8,9]. Certain variations in these genetic codes can weaken the disease, but can also increase its transmissibility, virulence, or ability to evade the bodys defense mechanisms [10]. The Omicron variant, or B.1.1.529 lineage, is one of the most recent variants to emerge as a result of the mutations that are currently distributing [11]. This variant offers 37 amino acid changes in the spike (S) protein (compared to the delta variant), 15 of which are in the receptor-binding website (RBD), which causes improved transmissibility [12]. A growing number of medical communities are now questioning whether the Omicron variant may provide natural immunity as a result of its milder symptoms [13]. However, it is unknown whether the milder symptoms are caused by the virus acting as a natural immunization or by the fact that much of the human population has been vaccinated. The reason behind this is that natural SARS-CoV-2 illness or vaccination results in the activation of complementary humoral (antibody) and cellular (T cell) immune reactions [14]. Furthermore, despite the fact that it is distributing rapidly, this variant has a low hospitalization rate. Many people believe that this variant can act as a natural immunization and may train a variety of human being immune systems. This review article discusses how the Omicron variant might or is probably not able to provide natural immunity. 2. SARS-CoV-2 Mutation Results in the Emergence of Various Variants Viruses develop constantly as a result of mutation, and fresh viral variants are almost particular to emerge. Occasionally, fresh variants appear and Peucedanol then perish, while others remain in existence for a long time. During this pandemic, a large number of different SARS-CoV-2 variants have been monitored all over the world. Viruses with mutations in their genomes will dominate the population, no matter their impact on viral fitness [7]. According to the Centers for Disease Control and Prevention (CDC), SARS-CoV-2 variants are classified into four classes, namely: variants being monitored (VBM), variants of interest Peucedanol (VOI), variants of concern (VOC), and variants of high result (VOHC) (https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html;.